112
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease

, , , , , & show all
Pages 107-116 | Published online: 04 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Kai Michael Beeh, Anne-Marie Kirsten, Ana-Maria Tanase, Alexia Richard, Weihua Cao, Bettina Hederer, Jutta Beier, Oliver Kornmann & Richard N van Zyl-Smit. (2018) Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3923-3936.
Read now
Bhumika Aggarwal & Jaideep Gogtay. (2014) Use of pressurized metered dose inhalers in patients with chronic obstructive pulmonary disease: review of evidence. Expert Review of Respiratory Medicine 8:3, pages 349-356.
Read now

Articles from other publishers (5)

Francesca Buttini, Irene Pasquali, Gaetano Brambilla, Diego Copelli, Massimiliano Dagli Alberi, Anna Giulia Balducci, Ruggero Bettini & Viviana Sisti. (2015) Multivariate Analysis of Effects of Asthmatic Patient Respiratory Profiles on the In Vitro Performance of a Reservoir Multidose and a Capsule-Based Dry Powder Inhaler. Pharmaceutical Research 33:3, pages 701-715.
Crossref
Daan A. De Coster & Melvyn Jones. (2014) Tailoring of corticosteroids in COPD management. Current Respiratory Care Reports 3:3, pages 121-132.
Crossref
Teddy Kosoglou, James Hubbell, Bhavna Kantesaria, Mary E. Hanson & David L. Cutler. (2014) An evaluation of the systemic bioavailability of mometasone furoate (MF) after oral inhalation from a MF/formoterol fumarate metered-dose inhaler versus an MF dry-powder inhaler in healthy subjects. Clinical Pharmacology in Drug Development 3:3, pages 229-234.
Crossref
Teddy Kosoglou, James Hubbell, Amy O. Johnson-Levonas, Mona Yunan, Bhavna S. Kantesaria & David L. Cutler. (2014) Evaluation of potential for pharmacokinetic interaction between mometasone furoate and formoterol fumarate after oral inhalation from a fixed-dose combination metered-dose inhaler device. Clinical Pharmacology in Drug Development 3:3, pages 222-228.
Crossref
Teddy Kosoglou, James Hubbell, David L. Cutler, Amy O. Johnson-Levonas, Danlin Xu, Bhavna S. Kantesaria, Kenneth Kim & S. David Miller. (2013) Hypothalamic-Pituitary-Adrenal Axis Effects of Mometasone Furoate/Formoterol Fumarate vs Fluticasone Propionate/Salmeterol Administered Through Metered-Dose Inhaler. Chest 144:6, pages 1795-1802.
Crossref